Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Sapan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biotechnology and Applied Biochemistry|February 1, 1997
Immunoglobulin stabilityC V Sapan
Biotechnology and Applied Biochemistry|March 17, 1999
Colorimetric protein assay techniquesC V Sapan, R L Lundblad, N C Price
Vox Sanguinis|March 14, 2007
Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeuticsC V Sapan, H M Reisner, R L Lundblad
The Journal of Infectious Diseases|November 7, 1998
Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and ThaisJ A Lynch, M deSouza, M D Robb, et al.
Journal of Virology|October 6, 1997
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12J R Mascola, M K Louder, T C VanCott, et al.
Journal of Virology|April 10, 1999
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodiesJ R Mascola, M G Lewis, G Stiegler, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
The Journal of Infectious Diseases|February 11, 2000
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273)E R Stiehm, C V Fletcher, L M Mofenson, et al.
The Journal of Infectious Diseases|February 10, 1999
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185E R Stiehm, J S Lambert, L M Mofenson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biotechnology and Applied Biochemistry|February 1, 1997
Immunoglobulin stabilityC V Sapan
Biotechnology and Applied Biochemistry|March 17, 1999
Colorimetric protein assay techniquesC V Sapan, R L Lundblad, N C Price
Vox Sanguinis|March 14, 2007
Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeuticsC V Sapan, H M Reisner, R L Lundblad
The Journal of Infectious Diseases|November 7, 1998
Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and ThaisJ A Lynch, M deSouza, M D Robb, et al.
Journal of Virology|October 6, 1997
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12J R Mascola, M K Louder, T C VanCott, et al.
Journal of Virology|April 10, 1999
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodiesJ R Mascola, M G Lewis, G Stiegler, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
The Journal of Infectious Diseases|February 11, 2000
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273)E R Stiehm, C V Fletcher, L M Mofenson, et al.
The Journal of Infectious Diseases|February 10, 1999
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185E R Stiehm, J S Lambert, L M Mofenson, et al.
Pageof 1